Sandoz logo
Adobe
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Avecho (ASX:AVE) has received a US$3 million (A$4.7 million) payment from pharma heavyweight Sandoz in exchange for the latter’s right to use Avecho’s licence for a CBD capsule sleeping pill.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

The term ‘CBD’ refers to the non-psychoactive element within marijuana (the bit that gets you high is called ‘THC’) which has been widely popular in recent years among both medical and recreation markets.

CBD is in just about everything from gummy bears, creams and lotions, roll-on sticks, eyedropper bottles, soft drinks, vand apes. The list goes on.

Whether or not it actually empirically works remains debated, but then again, most people will pay for peace of mind. If they perceive it works, it doesn’t matter.

Thus, the $4.7M from Sandoz.

Worth noting is Avecho’s share price is worth a sixth of a cent. So there’s that. It also has 3B shares on issue – so this payment from Sandoz is, most likely, quite welcome.

But the company stands to make a further US$16M in milestone payments, from Sandoz, should the latter continue progressing Avecho’s CBD capsule product towards commercial sales.

And then there are royalty payments – up to 19% – which makes you wonder if Sandoz truly intends to commercialise.

Or if they truly believe that these products could sell so spectacularly the cut-throat pharmaceutical giant is fine with a 19% royalty. (Sandoz is often accused of patent piracy, and it doesn’t mind a lawsuit.)

More market news

Never-ending: And just like that, Trump’s tariffs are back causing more market chaos

Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst

“The upfront licensing fee from Sandoz strengthens our financial position, providing the necessary support to accelerate ongoing research and commercial activities,” Avecho CEO Dr. Paul Gavin said.

Let’s hope Sandoz stays interested.

AVE last traded at 6cps.

Join the discussion: See what HotCopper users are saying about AVE and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

ave by the numbers
More From The Market Online
ASX Earnings concept

Week 8 CY26, Wrapped: Unusually quiet Trump amplifies ASX earnings, but Iran fears growing

It’s been an interesting two weeks, largely because we haven’t heard too much from Donald Trump lately.
The Market Online Video

Prospect Resources on ‘the copper capital of Africa’ and the tier-one mining potential in Zambia

Prospect Resources joins HotCopper to talk about why it's been looking into the underlying geology at…
The Market Online Video

Australian Gold and Copper: Maiden resource complete, growth story continues

HotCopper talks to AGC MD Glen Diemar as precious and critical metals explorer Australian Gold and…
The Market Online Video

HotCopper Highlights, Week 8: Zip unfastened; Coles in trouble, BHP’s India pivot & more

Good Afternoon and welcome to the latest edition of HotCopper Highlights where we go through the stocks and announcements you were watching this week on